Risperdal is a second-generation antipsychotic drug that was approved by the Food and Drug Administration (FDA) in 1993. It was originally approved by the FDA to treat schizophrenia in adults. The manufacturer of Risperdal, Janssen Pharmaceuticals, Inc., may have potentially known about the risks associated with this medication and not taken the proper steps to adequately warn consumers.
Over the years, however, a steadily increasing number of doctors have prescribed Risperdal for off-label (non-approved) uses that include treatment for dementia and behavioral disorders in elderly patients, attention deficit disorder (ADD) in preadolescents and teens, anxiety, and autism. While Risperdal does supply some off-label use benefits, there have been no clinical trials to determine such non-approved drug use safety. One of the most important and potentially life-altering side effects of Risperdal is gynecomastia, an enlargement of male breast tissue. Gynecomastia can cause severe psychological issues in adolescent males, because it is permanent and often requires surgery for removal of the excess breast tissue. Men who have been diagnosed with gynecomastia also have an increased chance of developing breast cancer. Other health risks associated with taking Risperdal include, but are not limited to:
- Heart attacks
- Immune system depression
- Rapid and extreme weight gain
Roberts and Roberts has been working for nearly 30 years to hold manufacturers accountable for their products and drugs. The wrongful death attorneys of Roberts and Roberts have the expertise and skill to get you the settlement you deserve. If you, or someone you know, have been prescribed Risperdal and have experienced serious or life-threatening side effects related to this medication, call us. The call costs you nothing... it could mean everything.